These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 11738349)

  • 41. Potentiation of the effects of chlorhexidine diacetate and cetylpyridinium chloride on mycobacteria by ethambutol.
    Broadley SJ; Jenkins PA; Furr JR; Russell AD
    J Med Microbiol; 1995 Dec; 43(6):458-60. PubMed ID: 7473681
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Anti-dormant Mycobacterial Activity of Viomellein and Xanthomegnin, Naphthoquinone Dimers Produced by Marine- derived Aspergillus sp.
    Kamiya K; Arai M; Setiawan A; Kobayashi M
    Nat Prod Commun; 2017 Apr; 12(4):579-581. PubMed ID: 30520600
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A fatal case of infection due to Mycobacterium bovis.
    Habib NI; Warring FC
    Am Rev Respir Dis; 1966 May; 93(5):804-10. PubMed ID: 5327835
    [No Abstract]   [Full Text] [Related]  

  • 44. Cytochemical and biological properties of Mycobacterium bovis BCG.
    Slosárek M
    Folia Microbiol (Praha); 1977; 22(4):262-8. PubMed ID: 330364
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Do new N-substituted 3-amino-4-phenyl-5-oxo-pyrazolinecarboxamide derivatives exhibit antitubercular potential?
    Swatko-Ossor M; Klimek K; Belcarz A; Kaczor AA; Pitucha M; Ginalska G
    Eur J Pharm Sci; 2018 Aug; 121():155-165. PubMed ID: 29802898
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Studies on the combined activity of tuberculostatic agents on tubercle bacilli. I. Studies on the activity of thioamide of alpha-ethyl-isonicotinic acid on acid fast bacilli in vitro].
    Manowska W
    Gruzlica; 1966 Nov; 34(11):963-8. PubMed ID: 4962783
    [No Abstract]   [Full Text] [Related]  

  • 47. In vitro anti-mycobacterial activities of three species of Cola plant extracts (Sterculiaceae).
    Adeniyi BA; Groves MJ; Gangadharam PR
    Phytother Res; 2004 May; 18(5):414-8. PubMed ID: 15174004
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Synthesis and antitubercular activity of new 1,3,4-oxadiazoles bearing pyridyl and thiazolyl scaffolds.
    Dhumal ST; Deshmukh AR; Bhosle MR; Khedkar VM; Nawale LU; Sarkar D; Mane RA
    Bioorg Med Chem Lett; 2016 Aug; 26(15):3646-51. PubMed ID: 27301367
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Biological evaluation of bisbenzaldehydes against four Mycobacterium species.
    Cappoen D; Forge D; Vercammen F; Mathys V; Kiass M; Roupie V; Anthonissen R; Verschaeve L; Vanden Eynde JJ; Huygen K
    Eur J Med Chem; 2013 May; 63():731-8. PubMed ID: 23567963
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Haliclonacyclamines, tetracyclic alkylpiperidine alkaloids, as anti-dormant mycobacterial substances from a marine sponge of Haliclona sp.
    Arai M; Ishida S; Setiawan A; Kobayashi M
    Chem Pharm Bull (Tokyo); 2009 Oct; 57(10):1136-8. PubMed ID: 19801875
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Synthesis of Arabino glycosyl triazoles as potential inhibitors of mycobacterial cell wall biosynthesis.
    Wilkinson BL; Long H; Sim E; Fairbanks AJ
    Bioorg Med Chem Lett; 2008 Dec; 18(23):6265-7. PubMed ID: 18926698
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Discovery of novel 5-(ethyl or hydroxymethyl) analogs of 2'-'up' fluoro (or hydroxyl) pyrimidine nucleosides as a new class of Mycobacterium tuberculosis, Mycobacterium bovis and Mycobacterium avium inhibitors.
    Shakya N; Srivastav NC; Bhavanam S; Tse C; Desroches N; Agrawal B; Kunimoto DY; Kumar R
    Bioorg Med Chem; 2012 Jul; 20(13):4088-97. PubMed ID: 22664188
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Empirical treatment of lower urinary tract infections in the face of spreading multidrug resistance: in vitro study on the effectiveness of nitroxoline.
    Sobke A; Makarewicz O; Baier M; Bär C; Pfister W; Gatermann SG; Pletz MW; Forstner C
    Int J Antimicrob Agents; 2018 Feb; 51(2):213-220. PubMed ID: 29111434
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Does resistance to pyrazinamide accurately indicate the presence of Mycobacterium bovis?
    de Jong BC; Onipede A; Pym AS; Gagneux S; Aga RS; DeRiemer K; Small PM
    J Clin Microbiol; 2005 Jul; 43(7):3530-2. PubMed ID: 16000498
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Isolation of mutants resistant to antituberculous drugs in wild strains of M. bovis].
    de Kantor IN; Lesslie IW
    Medicina (B Aires); 1974; 34(3):244-8. PubMed ID: 4212693
    [No Abstract]   [Full Text] [Related]  

  • 56. Genotyping and rifampicin and isoniazid resistance in Mycobacterium bovis strains isolated from the lymph nodes of slaughtered cattle.
    Franco MMJ; Ribeiro MG; Pavan FR; Miyata M; Heinemann MB; de Souza Filho AF; Cardoso RF; de Almeida AL; Sakate RI; Paes AC
    Tuberculosis (Edinb); 2017 May; 104():30-37. PubMed ID: 28454647
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Evaluation of the Mycobacterium smegmatis and BCG models for the discovery of Mycobacterium tuberculosis inhibitors.
    Altaf M; Miller CH; Bellows DS; O'Toole R
    Tuberculosis (Edinb); 2010 Nov; 90(6):333-7. PubMed ID: 20933470
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Design, synthesis and antitubercular potency of 4-hydroxyquinolin-2(1H)-ones.
    de Macedo MB; Kimmel R; Urankar D; Gazvoda M; Peixoto A; Cools F; Torfs E; Verschaeve L; Lima ES; Lyčka A; Milićević D; Klásek A; Cos P; Kafka S; Košmrlj J; Cappoen D
    Eur J Med Chem; 2017 Sep; 138():491-500. PubMed ID: 28689097
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Arylamine N-acetyltransferase is required for synthesis of mycolic acids and complex lipids in Mycobacterium bovis BCG and represents a novel drug target.
    Bhakta S; Besra GS; Upton AM; Parish T; Sholto-Douglas-Vernon C; Gibson KJ; Knutton S; Gordon S; DaSilva RP; Anderton MC; Sim E
    J Exp Med; 2004 May; 199(9):1191-9. PubMed ID: 15117974
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Overexpression of inhA, but not kasA, confers resistance to isoniazid and ethionamide in Mycobacterium smegmatis, M. bovis BCG and M. tuberculosis.
    Larsen MH; Vilchèze C; Kremer L; Besra GS; Parsons L; Salfinger M; Heifets L; Hazbon MH; Alland D; Sacchettini JC; Jacobs WR
    Mol Microbiol; 2002 Oct; 46(2):453-66. PubMed ID: 12406221
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.